Amneal Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.About AMRX
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog.
CEOChintu Patel
CEOChintu Patel
Employees8,300
Employees8,300
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2002
Founded2002
Employees8,300
Employees8,300
AMRX Key Statistics
Market cap3.29B
Market cap3.29B
Price-Earnings ratio1.62K
Price-Earnings ratio1.62K
Dividend yield—
Dividend yield—
Average volume1.71M
Average volume1.71M
High today$10.54
High today$10.54
Low today$10.32
Low today$10.32
Open price$10.40
Open price$10.40
Volume1.08M
Volume1.08M
52 Week high$10.68
52 Week high$10.68
52 Week low$6.69
52 Week low$6.69
AMRX News
Simply Wall St 1d
Does Amneal Pharmaceuticals Still Offer Value After 36% Surge and New Product Approvals in 2025?If you have ever wondered whether Amneal Pharmaceuticals deserves a spot in your portfolio, you are definitely not alone. With shares closing recently at $10.55...
Simply Wall St 5d
Amneal Strengthens Pipeline With FDA Advances but What Does This Mean for Its Growth Ambitions?In September 2025, Amneal Pharmaceuticals announced it had submitted a Biologics License Application to the FDA for a proposed biosimilar to XOLAIR and had rece...
People also own
Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.